BBLGWBone Biologics Corporation
14.50USD0.00%Mkt Cap: P/E:

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromoti…

Industry Peers

Chemicals
Screen all
Indicators:|

Key Statistics

Company
Market Cap
Enterprise Value
Revenue (TTM)
Gross Profit
Net Income (TTM)-3.11M $
Revenue/Share
Last Price14.50 USD
Fiscal Year End
MR Quarter
Employees2
CountryUS
SectorBasic Materials
IndustryChemicals
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B5.00
EPS (TTM)-0.14
EPS (Forward)
52W Range
8.30022% of range35.95
52W High35.95 USD
52W Low8.300 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-57.81%
ROA-53.64%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-2.69M $
CapEx (TTM)
FCF Margin
FCF Yield
Net Debt-4.53M $
Net Debt/EBITDA
Balance Sheet
Debt/Equity
Current Ratio16.09
Quick Ratio14.67
Book Value/Sh2.601 USD
Cash/Share2.523 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.
Float1.79M
Insiders
Institutions
Technical
SMA 5016.07 (-9.8%)
SMA 20018.04 (-19.6%)
Beta0.53
S&P 52W Chg20.25%
Avg Vol (30d)271
Avg Vol (10d)0
Technical Indicators
RSI (14)43.0
MACD-0.4926
MACD Signal-0.6693
MACD Hist.+0.1767
BB Upper15.87 USD
BB Middle14.37 USD
BB Lower12.87 USD
BB Width20.89%
ATR (14)0.3980 USD
Vol Ratio (20d)0.00x